Cargando…
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia
Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and e...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367777/ https://www.ncbi.nlm.nih.gov/pubmed/34422150 http://dx.doi.org/10.1016/j.radcr.2021.08.022 |
_version_ | 1783739084835913728 |
---|---|
author | Wakamatsu, Ikuo Yatomi, Masakiyo Uno, Shogo Oishi, Yuko Ikeuchi, Hidekazu Hanazato, Chiharu Sawada, Yuri Saito, Haruka Yamaguchi, Koichi Kasahara, Norimitsu Miura, Yosuke Tsurumaki, Hiroaki Hara, Kenichiro Koga, Yasuhiko Sunaga, Noriaki Hisada, Takeshi Hiromura, Keiju Maeno, Toshitaka |
author_facet | Wakamatsu, Ikuo Yatomi, Masakiyo Uno, Shogo Oishi, Yuko Ikeuchi, Hidekazu Hanazato, Chiharu Sawada, Yuri Saito, Haruka Yamaguchi, Koichi Kasahara, Norimitsu Miura, Yosuke Tsurumaki, Hiroaki Hara, Kenichiro Koga, Yasuhiko Sunaga, Noriaki Hisada, Takeshi Hiromura, Keiju Maeno, Toshitaka |
author_sort | Wakamatsu, Ikuo |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and evaluation of COVID-19 pneumonia and its complications. We encountered a case of a male patient with neurofibromatosis (type I) who developed concurrent pneumothorax and pleural effusion during his recovery period from severe COVID-19 pneumonia. Pulmonary fibrosis and emphysema were also confirmed. Furthermore, an eosinophil pleural effusion appeared and was prolonged during the healing process of COVID-19. This clinical presentation suggests that fibrosis and emphysema formation due to neurofibromatosis may have caused pneumothorax and pleural effusion. |
format | Online Article Text |
id | pubmed-8367777 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83677772021-08-17 A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia Wakamatsu, Ikuo Yatomi, Masakiyo Uno, Shogo Oishi, Yuko Ikeuchi, Hidekazu Hanazato, Chiharu Sawada, Yuri Saito, Haruka Yamaguchi, Koichi Kasahara, Norimitsu Miura, Yosuke Tsurumaki, Hiroaki Hara, Kenichiro Koga, Yasuhiko Sunaga, Noriaki Hisada, Takeshi Hiromura, Keiju Maeno, Toshitaka Radiol Case Rep Case Report Coronavirus disease 2019 (COVID-19) has become a global pandemic since its discovery in December 2019, and as the disease continues to evolve, varying complications associated with it continue to arise. In this regard, computed tomography has played an extremely important role in the diagnosis and evaluation of COVID-19 pneumonia and its complications. We encountered a case of a male patient with neurofibromatosis (type I) who developed concurrent pneumothorax and pleural effusion during his recovery period from severe COVID-19 pneumonia. Pulmonary fibrosis and emphysema were also confirmed. Furthermore, an eosinophil pleural effusion appeared and was prolonged during the healing process of COVID-19. This clinical presentation suggests that fibrosis and emphysema formation due to neurofibromatosis may have caused pneumothorax and pleural effusion. Elsevier 2021-08-17 /pmc/articles/PMC8367777/ /pubmed/34422150 http://dx.doi.org/10.1016/j.radcr.2021.08.022 Text en © 2021 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Wakamatsu, Ikuo Yatomi, Masakiyo Uno, Shogo Oishi, Yuko Ikeuchi, Hidekazu Hanazato, Chiharu Sawada, Yuri Saito, Haruka Yamaguchi, Koichi Kasahara, Norimitsu Miura, Yosuke Tsurumaki, Hiroaki Hara, Kenichiro Koga, Yasuhiko Sunaga, Noriaki Hisada, Takeshi Hiromura, Keiju Maeno, Toshitaka A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia |
title | A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia |
title_full | A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia |
title_fullStr | A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia |
title_full_unstemmed | A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia |
title_short | A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumonia |
title_sort | case of a patient with neurofibromatosis type i who developed pneumothorax and eosinophilic pleural effusion after suffering from covid-19 pneumonia |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8367777/ https://www.ncbi.nlm.nih.gov/pubmed/34422150 http://dx.doi.org/10.1016/j.radcr.2021.08.022 |
work_keys_str_mv | AT wakamatsuikuo acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT yatomimasakiyo acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT unoshogo acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT oishiyuko acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT ikeuchihidekazu acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT hanazatochiharu acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT sawadayuri acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT saitoharuka acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT yamaguchikoichi acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT kasaharanorimitsu acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT miurayosuke acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT tsurumakihiroaki acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT harakenichiro acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT kogayasuhiko acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT sunaganoriaki acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT hisadatakeshi acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT hiromurakeiju acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT maenotoshitaka acaseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT wakamatsuikuo caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT yatomimasakiyo caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT unoshogo caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT oishiyuko caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT ikeuchihidekazu caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT hanazatochiharu caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT sawadayuri caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT saitoharuka caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT yamaguchikoichi caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT kasaharanorimitsu caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT miurayosuke caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT tsurumakihiroaki caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT harakenichiro caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT kogayasuhiko caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT sunaganoriaki caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT hisadatakeshi caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT hiromurakeiju caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia AT maenotoshitaka caseofapatientwithneurofibromatosistypeiwhodevelopedpneumothoraxandeosinophilicpleuraleffusionaftersufferingfromcovid19pneumonia |